Digitalization has swept the Chinese medicine industry and will continue to empower the development of Chinese medicine enterprises

【Pharmaceutical Network Market Analysis】With the continuous growth of domestic pharmaceutical and health demand, as well as the development of new technologies such as the Internet, big data, and artificial intelligence, China's traditional Chinese medicine industry is actively introducing "digitalization" to empower the industry
.
Digitalization has swept the traditional Chinese medicine industry and will continue to empower the development of traditional Chinese medicine enterprises (Image source: Pharmaceutical Network) Recently, Yunnan Province's first self-built professional digital platform for traditional Chinese medicinal materials-Yunnan Province's traditional Chinese medicinal materials industry information public service platform "Digital Cloud Medicine" has been officially put into operation
.
According to reports, "Digital Cloud Medicine" is built by the Yunnan Province Traditional Chinese Medicine Planting and Breeding Industry Association, integrating industrial big data content such as Chinese herbal medicine technical service platform, standard service platform, traceability service platform and digital supply chain construction
.
After the platform is launched, it will provide one-stop public services such as price inquiry (trend), supply and demand release, variety analysis, market forecasting, industrial early warning, cloud drug traceability, and intelligent management for Chinese medicinal materials planting enterprises, industrial production enterprises, commercial circulation enterprises and government regulatory departments, so as to help the digitalization and digital industrialization of
the cloud medicine industry.
In addition to the online operation of "Digital Cloud Medicine", the launch ceremony of the "China (Zhangshu) Chinese Medicinal Materials Industry Digital Platform" built by Jiangxi Supply and Marketing Cloud Medicinal Materials Technology Co.
, Ltd.
was also held
in Qihuang Town on October 28.
The platform is jointly built by Zhangshu Municipal People's Government and Jiangxi Supply and Marketing Cloud Medicinal Materials Technology Co.
, Ltd.
, with a total planned investment of 2 billion yuan
.
The platform uses the new model of "Internet + Chinese medicine" and adopts artificial intelligence, blockchain, big data, Internet of Things and cloud computing technologies to build a Chinese herbal medicine information service platform, online trading platform, supply chain finance platform, digital warehousing and logistics platform and Chinese herbal medicine quality traceability platform, which can provide information, trading, supply chain finance, warehousing and logistics, traceability, testing and other services
for upstream and downstream users of the Chinese herbal medicine industry chain 。 Industry analysts believe that the digital platform of traditional Chinese medicine can widely connect the originators, operating enterprises, medical institutions (including Internet hospitals) and patients of traditional Chinese medicinal materials, open up information flow, logistics, bill flow and capital flow, establish the whole process quality control and traceability from the place of origin to the patient, and realize the integrated online service
of joint procurement, negotiation, trading, payment, settlement and supervision.
Therefore, in the future, the use of digital technology platform will continue to liberate the manpower of Chinese medicine enterprises, improve production management efficiency, and further ensure output and quality
.
In fact, digital transformation has swept the traditional Chinese medicine industry, and many traditional Chinese medicine companies have already begun to accelerate transformation and upgrading with the help of digital technology and equipment, and have achieved certain results
.
For example, Tasly has built an artificial intelligence big data platform with independent intellectual property rights, which has promoted the leapfrog development
of traditional Chinese medicine to digital Chinese medicine research and development.
At present, the platform has successfully accumulated 60T of massive characteristic medical data resources, built a multi-dimensional database covering disease multi-omics, Chinese medicinal materials-ingredients-targets, drug small molecules, etc.
, and built more than 30 analysis pipelines such as AI disease network, biomedical knowledge graph, and drug relocation
.
Hanwang Pharmaceutical, on the other hand, is continuously improving product quality and expanding the scale
of its enterprises by introducing digital Chinese medicine production lines.
It is reported that Hanwang Pharmaceutical has abandoned the traditional production method that consumes manpower and material resources and introduced a complete set of conjoined modern traditional Chinese medicine preparation equipment
.
The fully integrated and automated production workshop not only improves production efficiency, but also improves product quality and further empowers
the development of enterprises.
In addition, Yunnan Baiyao has also created a "digital Sanqi industry platform" through the use of 5G, industrial Internet, big data, artificial intelligence, blockchain and other technologies, which can realize "source can be checked, whereabouts can be traced, and responsibilities can be investigated", helping Yunnan Sanqi industry embark on the road
of standardized and standardized transformation and upgrading.
Industry analysts believe that under the promotion of policies and industries, the degree of digitalization of traditional Chinese medicine is continuing to increase
.
In the future, as more industry enterprises continue to research in the field of "digitalization + traditional Chinese medicine", upgrading equipment will surely empower the high quality of the traditional Chinese medicine industry
.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.